Symbol="ALNY"
AssetType="Common Stock"
Name="Alnylam Pharmaceuticals Inc"
Description="Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing and commercializing RNA interference (RNAi) therapies. The company is headquartered in Cambridge, Massachusetts."
CIK="1178670"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="675 WEST KENDALL STREET, HENRI A. TERMEER SQUARE, CAMBRIDGE, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="23541641000"
EBITDA="-739073984"
PERatio="None"
PEGRatio="-0.49"
BookValue="-2.087"
DividendPerShare="0"
DividendYield="0"
EPS="-8.74"
RevenuePerShareTTM="9.32"
ProfitMargin="-0.931"
OperatingMarginTTM="-0.689"
ReturnOnAssetsTTM="-0.144"
ReturnOnEquityTTM="-15.01"
RevenueTTM="1143449000"
GrossProfitTTM="868601000"
DilutedEPSTTM="-8.74"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0.497"
AnalystTargetPrice="248.08"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="29.37"
PriceToBookRatio="142.92"
EVToRevenue="28.64"
EVToEBITDA="-29.42"
Beta="0.482"
num_52WeekHigh="242.97"
num_52WeekLow="179.19"
num_50DayMovingAverage="194.92"
num_200DayMovingAverage="206.79"
SharesOutstanding="124526000"
DividendDate="None"
ExDividendDate="None"
symbol="ALNY"
open="186.80"
high="187.50"
low="184.16"
price="187.01"
volume="631454.00"
latest_trading_day="2023-08-02"
previous_close="189.05"
change="-2.04"
change_percent="-1.0791%"
aroon_positive_momentum_days="32"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="32"
Volume_recent_avg="662499"
Change_recent_avg="-0.13"
Delta_recent_avg="5.63"
Variance_recent_avg="2.81"
Change_ratio_recent_avg="-0.08"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="32"
Aroon_momentum_negative="68"
image_negative_thumbnail_id_1="1154"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0188.jpeg"
image_negative_thumbnail_id_2="1108"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0141.jpeg"
image_neutral_thumbnail_id_1="535"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0064.jpeg"
image_neutral_thumbnail_id_2="574"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0025.jpeg"
image_positive_thumbnail_id_1="633"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0075.jpeg"
image_positive_thumbnail_id_2="1006"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0168.jpeg"
image_professor_thumbnail_id_1="1179"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0013.jpeg"
image_professor_thumbnail_id_2="1167"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0001.jpeg"
